Suppr超能文献

帕金森病中针对小分子热休克蛋白的体液免疫反应。

Humoral response against small heat shock proteins in Parkinson's disease.

作者信息

Papuć Ewa, Kurys-Denis Ewa, Krupski Witold, Rejdak Konrad

机构信息

Chair and Department of Neurology of Medical University, Lublin, Poland.

2nd Department of Radiology, Medical University, Lublin, Poland.

出版信息

PLoS One. 2015 Jan 28;10(1):e0115480. doi: 10.1371/journal.pone.0115480. eCollection 2015.

Abstract

INTRODUCTION

In the light of evidence for the increased heat shock proteins (HSP) expression in neurodegenerative disorders, the presence of the adaptive humoral response of the immune system can be expected. The aim of the study was to check whether Parkinson's disease (PD) has the ability to elicit immune response against small heat shock proteins.

METHODS

IgG and IgM autoantibodies against alpha B-crystallin were assessed in 26 PD patients 26 healthy subjects. For the assessment of anti-HSP IgG autoantibodies serum samples from 31 parkinsonian patients and 31 healthy control subjects were collected. Serum samples from PD patients and healthy control subjects were collected twice, at baseline and after mean of 13 months follow up.

RESULTS

Both IgM and IgG autoantibodies against alpha ß-crystallin in PD patients were significantly higher compared to healthy controls (p<0.05). We also found statistically significant increase in antibodies titers against alpha ß-crystallin over the time of 13 months, both for IgG (p = 0.021) and for IgM (p<0.0001). Additionally, PD patients presented higher levels of anti-HSP IgG autoantibodies than healthy controls (p = 0.02).

CONCLUSIONS

Increase of IgG and IgM autoantibodies against alpha B-crystallin in PD patients over time may suggest their involvement in the disease pathogenesis and progression. Further studies are required to confirm the role of this antibody as a biomarker of the disease progression.

摘要

引言

鉴于神经退行性疾病中热休克蛋白(HSP)表达增加的证据,可以预期免疫系统存在适应性体液反应。本研究的目的是检查帕金森病(PD)是否有能力引发针对小分子热休克蛋白的免疫反应。

方法

评估了26例PD患者和26例健康受试者中针对αB-晶状体蛋白的IgG和IgM自身抗体。为了评估抗HSP IgG自身抗体,收集了31例帕金森病患者和31例健康对照受试者的血清样本。PD患者和健康对照受试者的血清样本在基线时和平均随访13个月后收集了两次。

结果

与健康对照相比,PD患者中针对αβ-晶状体蛋白的IgM和IgG自身抗体均显著更高(p<0.05)。我们还发现,在13个月的时间里,针对αβ-晶状体蛋白的抗体滴度在IgG(p = 0.021)和IgM(p<0.0001)方面均有统计学上的显著增加。此外,PD患者的抗HSP IgG自身抗体水平高于健康对照(p = 0.02)。

结论

随着时间的推移,PD患者中针对αB-晶状体蛋白的IgG和IgM自身抗体增加,这可能表明它们参与了疾病的发病机制和进展。需要进一步的研究来证实这种抗体作为疾病进展生物标志物的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验